HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals.

Abstract
Chronic hepatitis C (HCV) virus infection may be associated with several non-hepatic manifestations, mainly driven by chronic immune stimulation, such as mixed cryoglobulinemia and Non-Hodgkin's Lymphoma. This association has been proved by several meta-analyses and some interventional studies demonstrating that antiviral treatment may be effective in inducing HCV-associated lymphoma regression. The recent advent of direct acting antivirals (DAAs) in the therapeutic armamentarium of HCV infection made possible treatment of patients with advanced liver disease. Here we report on a rare association of a cirrhotic patient with HCV and Waldenström's Macroglobulinemia with severe cryoglobulinemia, who had already failed an interferon-based antiviral regimen, whose haematologic disease was ameliorated by HCV eradication following treatment with sofosbuvir and simeprevir with ribavirin, and where successful treatment was accompanied also by consistent improvement in liver function and parameters of portal hypertension.
AuthorsMattia Crespi, Maria Giulia Demarzo, Matteo Brunacci, Gaia Pellegatta, Fabio Ferrando, Alberto Ballestrero, Federica Grillo, Vincenzo Savarino, Edoardo G Giannini
JournalAnnals of hepatology (Ann Hepatol) Vol. 17 Issue 6 Pg. 1072-1077 (10 16 2018) ISSN: 1665-2681 [Print] Mexico
PMID30600285 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antiviral Agents
  • Simeprevir
  • Sofosbuvir
Topics
  • Antiviral Agents (therapeutic use)
  • Biopsy, Needle
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Hepatitis C, Chronic (complications, drug therapy, pathology)
  • Humans
  • Immunohistochemistry
  • Liver Cirrhosis (drug therapy, pathology, virology)
  • Middle Aged
  • Severity of Illness Index
  • Simeprevir (therapeutic use)
  • Sofosbuvir (therapeutic use)
  • Treatment Outcome
  • Waldenstrom Macroglobulinemia (complications, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: